Center for Public Health Innovation, CI International, Littleton, Colorado, United States of America.
Department of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado, United States of America.
PLoS One. 2020 Apr 2;15(4):e0231050. doi: 10.1371/journal.pone.0231050. eCollection 2020.
Newborn screening (NBS) aims to achieve early identification and treatment of affected infants prior to onset of symptoms. The timely completion of each step (i.e., specimen collection, transport, testing, result reporting), is critical for early diagnosis. Goals developed by the Secretary of Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) for NBS timeliness were adopted (time-critical results reported by five days of life, and non-time-critical results reported by day seven), and implemented into a multi-year quality improvement initiative (NewSTEPS 360) aimed to decrease the time to result reporting and intervention.
The NBS system from specimen collection through reporting of results was assessed (bloodspot specimen collection, specimen shipping, sample testing, and result reporting). Annual data from 25 participating NBS programs were analyzed; the medians (and interquartile range, IQR) of state-specific percent of specimens that met the goal are presented.
The percent of specimens collected before 48 hours of life increased from 95% (88-97%) in 2016 to 97% (IQR 92-98%) in 2018 for the 25 states, with 20 (80%) of programs collecting more than 90% of the specimens within 48 hours of birth. Approximately 41% (IQR 29-57%) of specimens were transported within one day of collection. Time-critical result reporting in the first five days of life improved from 49% (IQR 26-74%) in 2016 to 64% (42%-71%) in 2018, and for non-time critical results from 64% (IQR 58%-78%) in 2016 to 81% (IQR 68-91%) in 2018. Laboratories open seven days a week in 2018 reported 95% of time-critical results within five days, compared to those open six days (62%), and five days (45%).
NBS programs that participated in NewSTEPs 360 made great strides in improving timeliness; however, ongoing quality improvement efforts are needed in order to ensure all infants receive a timely diagnosis.
新生儿筛查(NBS)旨在在症状出现之前对受影响的婴儿进行早期识别和治疗。每个步骤(即标本采集、运输、检测、结果报告)的及时完成对早期诊断至关重要。卫生与公众服务部遗传疾病新生儿和儿童咨询委员会(ACHDNC)制定的 NBS 及时性目标(生命前五天报告时间关键结果,生命前七天报告非时间关键结果)已被采用,并实施了一项为期多年的质量改进计划(NewSTEPS 360),旨在缩短结果报告和干预的时间。
从标本采集到结果报告,评估 NBS 系统(血斑标本采集、标本运输、样本检测和结果报告)。对 25 个参与 NBS 项目的年度数据进行分析;呈现了各州符合目标的标本百分比的中位数(和四分位距,IQR)。
在 25 个州中,生命前 48 小时采集的标本百分比从 2016 年的 95%(88-97%)增加到 2018 年的 97%(IQR 92-98%),其中 20 个(80%)项目在出生后 48 小时内采集了超过 90%的标本。大约 41%(IQR 29-57%)的标本在采集后一天内运输。生命前五天的时间关键结果报告从 2016 年的 49%(IQR 26-74%)提高到 2018 年的 64%(42%-71%),非时间关键结果从 2016 年的 64%(IQR 58%-78%)提高到 2018 年的 81%(IQR 68-91%)。2018 年每周七天开放的实验室报告了 95%的时间关键结果在五天内,而每周六天(62%)和五天(45%)开放的实验室则报告了 95%的时间关键结果。
参与 NewSTEPS 360 的 NBS 项目在提高及时性方面取得了重大进展;然而,为了确保所有婴儿都能及时得到诊断,仍需要持续进行质量改进工作。